Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19

The current outbreak of coronavirus SARS-CoV-2 has reached multiple countries worldwide. While the number of newly diagnosed cases and fatalities is rising quickly, far-reaching measures were enacted to prevent further spread. Diagnosis relies on clinical presentation, exposure history, PCR using specimens from the respiratory tract together with computed tomography (CT) imaging. One of the hallmarks of a critical course of COVID-19 is the development of severe acute respiratory distress syndrome (ARDS). As management of COVID-19 can be considered a multi-disciplinary approach involving various medical specialties, we here review the first 18F-FDG-PET/CT scans of COVID-19 to discuss how Nuclear Medicine could contribute to management of this disease.

[1]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[2]  Z. Fayad,et al.  CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) , 2020, Radiology.

[3]  R. Pyzalski,et al.  Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques. , 2000, Virology.

[4]  J. Hatazawa,et al.  Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences , 2020, The Journal of Nuclear Medicine.

[5]  J. Hoffman,et al.  FDG-PET in patients at risk for acute respiratory distress syndrome: a preliminary report , 2008, Intensive Care Medicine.

[6]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[7]  Hyun Jung Koo,et al.  Radiographic and CT Features of Viral Pneumonia. , 2018, Radiographics : a review publication of the Radiological Society of North America, Inc.

[8]  S. Balakrishnan,et al.  Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. , 2020, AJR. American journal of roentgenology.

[9]  Melina Hosseiny,et al.  Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. , 2020, AJR. American journal of roentgenology.

[10]  M. Bauer,et al.  Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020 , 2020, Der Anaesthesist.

[11]  F. Fazio,et al.  Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study , 2009, Critical care medicine.

[12]  Philip J. Sayre,et al.  Modeling [18F]-FDG lymphoid tissue kinetics to characterize nonhuman primate immune response to Middle East respiratory syndrome-coronavirus aerosol challenge , 2015, EJNMMI Research.

[13]  Jing-Yuan Fang,et al.  Novel coronavirus infection and gastrointestinal tract (vol 21, pg 125, 2020) , 2020 .

[14]  Sijuan Zou,et al.  FDG PET/CT of COVID-19 , 2020, Radiology.

[15]  Edward Y Lee,et al.  Middle East Respiratory Syndrome Coronavirus: What Does a Radiologist Need to Know? , 2016, AJR. American journal of roentgenology.

[16]  Z. Fayad,et al.  Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection , 2020, Radiology.

[17]  F. Bengel,et al.  Myocardial Inflammation Predicts Remodeling and Neuroinflammation After Myocardial Infarction. , 2018, Journal of the American College of Cardiology.

[18]  Fang Liu,et al.  18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  A. Nordin,et al.  PET/CT in nononcological lung diseases: current applications and future perspectives , 2016, European Respiratory Review.